WallStSmart
IMNM

Immunome Inc

NASDAQ: IMNM · HEALTHCARE · BIOTECHNOLOGY

$22.95
-3.21% today

Updated 2026-04-29

Market cap
$2.60B
P/E ratio
P/S ratio
374.45x
EPS (TTM)
$-2.43
Dividend yield
52W range
$7 – $28
Volume
1.2M

Immunome Inc (IMNM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
+2.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+31.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.0%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-9.0%
2025-08-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.76-30.6%$20.62$20.01-3.0%
2025-11-07$-0.65-14.0%$15.50$16.44+6.1%
2025-08-06$-0.50+19.6%$10.85$9.87-9.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.58$-0.76-30.6%
2025-09-30$-0.57$-0.65-14.0%
2025-06-30$-0.62$-0.50+19.6%$4.01M+69.8%
2025-03-31$-0.81$-0.52+35.8%$2.93M+184.4%
2024-12-31$-0.61$-1.11-82.7%$2.74M-28.4%
2024-09-30$-0.56$-0.78-39.3%$2.91M-18.4%
2024-06-30$-0.39$-0.49-25.6%$2.36M-44.5%
2024-03-31$-0.69$-2.51-263.8%$1.03M
2023-12-31$-0.28$-4.22-1407.1%$3.83M
2023-09-30$-0.17$-0.36-111.8%$3.56M
2023-06-30$-0.16$-0.46-187.5%$4.26M

Frequently asked questions

Has Immunome Inc beaten earnings estimates?
Immunome Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of +2.7% over the last 4 quarters.
How does IMNM stock react to earnings?
IMNM stock has moved an average of -2.0% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.